First identified as regulators of larval development in nematodes 1,2 , microRNAs (miRNAs) are now known to serve key roles in the regulation of almost every important cellular process in all multicellular eukaryotes 3 . Human cells encode over 1,000 miRNA species, and these have been linked to cellular differentiation, innate immunity, apoptosis and oncogenic transformation, as well as many other cellfate 'decisions' 3 . Almost all cellular miRNAs are first transcribed as capped, polyadenylated primary miRNA transcripts that can encompass one or a cluster of miRNAs about 22 nucleotides in length 4 . These miRNAs occupy the upper part of an imperfect stem of about 33 base pairs that is crowned by a large unstructured loop of ten nucleotides or more and is flanked by single-stranded RNA. This RNA structure, about 80 nucleotides in length, is recognized by the nuclear 'microprocessor' consisting of the RNase III enzyme Drosha and the doublestranded RNA-binding protein DGCR8, which cleaves the stem approximately 22 base pairs from the stem-loop junction to generate the pre-miRNA hairpin intermediate about 60 nucleotides in length 5, 6 . Pre-miRNAs are bound by the nuclear export factor exportin 5, which transports them into the cytoplasm 7 . There, the pre-miRNA is bound by a second RNase III enzyme, Dicer, which cleaves the pre-miRNA at the stem-loop junction 8 . The resultant miRNA duplex intermediate then interacts with one of the four mammalian argonaut proteins, which incorporates one RNA strand to form the RNA-induced silencing complex (RISC) while the second RNA strand is degraded [9] [10] [11] . Discrimination between the strands is thought to be regulated by the stability of the ends of the duplex, with the strand whose 5′ end has base pairing that is less tight being favored for incorporation into RISC 12,13 . However, such discrimination is rarely complete, so both the major miRNA strand and minor, 'star' strand of the duplex intermediate are often detectable in the RISC.
r e v i e w First identified as regulators of larval development in nematodes 1,2 , microRNAs (miRNAs) are now known to serve key roles in the regulation of almost every important cellular process in all multicellular eukaryotes 3 . Human cells encode over 1,000 miRNA species, and these have been linked to cellular differentiation, innate immunity, apoptosis and oncogenic transformation, as well as many other cellfate 'decisions' 3 . Almost all cellular miRNAs are first transcribed as capped, polyadenylated primary miRNA transcripts that can encompass one or a cluster of miRNAs about 22 nucleotides in length 4 . These miRNAs occupy the upper part of an imperfect stem of about 33 base pairs that is crowned by a large unstructured loop of ten nucleotides or more and is flanked by single-stranded RNA. This RNA structure, about 80 nucleotides in length, is recognized by the nuclear 'microprocessor' consisting of the RNase III enzyme Drosha and the doublestranded RNA-binding protein DGCR8, which cleaves the stem approximately 22 base pairs from the stem-loop junction to generate the pre-miRNA hairpin intermediate about 60 nucleotides in length 5, 6 . Pre-miRNAs are bound by the nuclear export factor exportin 5, which transports them into the cytoplasm 7 . There, the pre-miRNA is bound by a second RNase III enzyme, Dicer, which cleaves the pre-miRNA at the stem-loop junction 8 . The resultant miRNA duplex intermediate then interacts with one of the four mammalian argonaut proteins, which incorporates one RNA strand to form the RNA-induced silencing complex (RISC) while the second RNA strand is degraded [9] [10] [11] . Discrimination between the strands is thought to be regulated by the stability of the ends of the duplex, with the strand whose 5′ end has base pairing that is less tight being favored for incorporation into RISC 12, 13 . However, such discrimination is rarely complete, so both the major miRNA strand and minor, 'star' strand of the duplex intermediate are often detectable in the RISC.
Once loaded into the RISC, the miRNA serves as a guide RNA to target the RISC to mRNAs bearing sequence complementarity 14 . If this complementarity is essentially complete, binding to the RISC can induce endonucleolytic cleavage and considerable mRNA destabilization. However, if the target mRNA is only partially complementary, binding to the RISC induces translational inhibition, sometimes followed by deadenylation and mRNA destabilization 15, 16 . For mRNA targets that are only partially complementary, the key is the complementarity between the so-called miRNA 'seed region' (positions 2-8 from the 5′ end) and the mRNA target 17, 18 . As a result, miRNAs that share a common seed region have very similar mRNA targets, even if the remainder of the miRNA is different in sequence.
Because seven nucleotides of sequence complementarity are sufficient, at least in principle, to allow inhibition of an mRNA by a given miRNA, it is easy to calculate that each miRNA has the potential to target a large number of cellular mRNAs, even allowing for the fact that many complementary target sites on mRNAs may be occluded by RNA secondary structure or by bound proteins. Initial efforts to identify the full complement of mRNA targets (the 'targetome') of a given miRNA by relying on bioinformatics resulted in long lists of potential mRNA targets and has not proven particularly reliable, although such methods continue to improve. A more sophisticated approach uses assays that measure global gene expression in the presence or absence of a given miRNA (for example, using mRNA microarrays) to identify mRNAs whose expression is specifically inhibited. If an mRNA identified in this way also contains a computationally predicted target site for that miRNA, then this provides a priori evidence in favor of the hypothesis that this is indeed a target 19 . Additional methods have been developed to directly recover and deep sequence RISC-binding sites on mRNA through the use of mRNA-protein crosslinking followed by immunoprecipitation (CLIP) with a RISC component such as argonaut 2 (refs. 20-23) . Such CLIP approaches have proven to be a very powerful tool for the global recovery of RISC target sites, with the main remaining difficulty being the accurate identification of which miRNA is actually responsible for mediating recruitment of the RISC to the mRNA. r e v i e w Discovery and expression pattern of viral miRNA Given the small sizes of miRNAs, their lack of antigenicity and their ability to post-transcriptionally inhibit the expression of specific mRNA species, miRNAs would seem to represent ideal tools for use by viruses to inhibit the expression of proteins that might act as inhibitors of viral replication, including especially mediators of antiviral innate immunity. The first viral miRNAs were discovered in 2003 in human B cells latently infected with the γ-herpesvirus EpsteinBarr virus (EBV) 24 , and subsequent papers identifying miRNAs in several other human and animal herpesviruses rapidly followed 25 ( Table 1 ). In addition, several human and animal polyomaviruses have been found to each encode a single pre-miRNA, whereas human adenoviruses have been proposed to encode two pre-miRNAs 25 . In contrast, no miRNAs have been identified in human papillomaviruses or poxviruses, which are also DNA viruses 26, 27 , and no human RNA virus, including human immunodeficiency virus type 1 (HIV-1), hepatitis C virus (HCV) and influenza B virus, has so far been shown to express any viral miRNAs [28] [29] [30] . This may relate to the fact that excision of a pre-miRNA stem-loop from an RNA virus genome would result in the cleavage of that genome, which might inhibit viral replication. Indeed, insertion of primary miRNA stem-loops into the genome of HIV-1-based vectors does diminish vector titers, especially if multiple stem-loops are inserted (B.R.C., unpublished observations).
Because most known viral miRNAs are encoded by herpesviruses, I will focus in this Review on the genus Herpesvirus and in particular on EBV, Kaposi's sarcoma-associated herpesvirus (KSHV) and human cytomegalovirus (HCMV), with only occasional reference to other viral species that infect humans or animals.
It is now known that EBV encodes 25 premiRNAs in two distinct clusters: the BHRF1 cluster, which includes 3 pre-miRNAs; and the BART cluster, which includes 22 premiRNAs 24, 31, 32 (Fig. 1) . Expression of these two clusters of miRNA differs depending on the latency stage of the virus. Infection of primary B cells with EBV results in establishment of the latency III stage, marked by high expression of the three BHRF1 miRNAs and moderate expression of the BART miRNAs. In contrast, cells recovered from EBVinduced nasopharyngeal carcinomas, as well as from B cell primary effusion lymphomas, in which EBV is in the latency II stage, are characterized by abundant expression of BART miRNAs and a total lack of expression of BHRF1 miRNAs 31 . Mutational analysis of the EBV genome has demonstrated that the BHRF1 miRNAs, which have high expression in the transformed lymphoblastoid cell lines that result from infection of primary B cells, are important but not essential for the outgrowth of lymphoblastoid cell lines, and that lymphoblastoid cell lines lacking these viral miRNAs grow more slowly than do lymphoblastoid cell lines infected with wild-type EBV 33, 34 . In contrast, the BART miRNAs do not affect the transformation of B cells by EBV in culture. As there is no in vitro model with which to study the transformation of epithelial cells by EBV, it remains unclear whether the BART miRNAs have a role in the initiation or maintenance of epithelial cell-derived tumors, such as nasopharyngeal carcinomas.
The oncogenic human γ-herpesvirus KSHV encodes a single cluster of 12 pre-miRNAs with high expression in latently KSHV-infected B cells 28, 35 (Fig. 1) . The sequences encoding ten of the twelve viral premiRNAs are located in an intron, whereas the sequences encoding the other two, miR-K10 and miR-K12, are unusually located in the viral K12 open reading frame and in the K12 mRNA 3′ untranslated region (UTR), respectively. The processing of miR-K10 and miR-K12 seems to be inefficient, which allows expression of the viral K12 protein 36 . Whether any of these miRNAs are important for the transformation of B cells by KSHV remains unclear, as there is no in vitro model now available that accurately measures KSHV-mediated transformation. Nevertheless, several mRNA targets for the KSHV miRNAs have been identified, and these data strongly suggest that viral miRNAs probably do contribute to viral transformation. Of interest, although all 12 KSHV pre-miRNAs are expressed during latency, this miRNA cluster also contains a lytic viral promoter, located immediately 5′ to the viral K12 open reading frame, that strongly induces the expression of not only the gene encoding the K12 protein but also viral miR-K10 and miR-K12 during lytic reactivation 36 . However, it remains unclear what roles these two miRNAs serve during productive KSHV replication.
Finally, HCMV is very different from both EBV and KSHV in that the sequences encoding the 12 known HCMV pre-miRNAs are scattered throughout the entire viral genome and thus are transcribed by several different promoter elements 28, 37 (Fig. 1) . Curiously, no report of HCMV miRNA expression during viral latency has appeared so far. However, all 12 HCMV pre-miRNAs have substantial expression during HCMV lytic replication. As there is no animal model now available with which to analyze the replication and pathogenicity of Virus-encoded miRNAs mediate evasion of the immune system As noted above, obvious potential host targets for virus-encoded miRNAs include factors that form part of the innate antiviral immune response, including factors that promote apoptosis or cell-cycle arrest or factors that help to recruit effector cells of the immune system to virusinfected cells. Many such targets have been proposed, but instead of providing a comprehensive list of proposed targets, I will focus here on the host mRNA targets of miRNAs encoded by EBV, KSHV or HCMV whose identification is supported by several different lines of evidence and/or by data from more than one laboratory and that also illustrate the kinds of targets of viral miRNA that have the potential to enhance viral replication or pathogenicity in vivo ( Table 2) .
One of the first host cellular mRNA targets reported for EBV miRNA was mRNA encoding PUMA (tumor suppressor p53-upregulated mediator of apoptosis), proposed to be a target of miR-BART5 (ref. 39 ). That in turn was proposed to protect EBV-infected nasopharyngeal carcinoma cells from apoptosis induced by DNAdamaging reagents. Infection with EBV is in fact known to induce a cellular DNA-damage response, and attenuation of this response has been shown to substantially enhance the efficiency of transformation of B cells by EBV 40 . A second target for miR-BART19 in the 3′ UTR of PUMA mRNA has been identified by CLIP 21 , which further supports the proposal of the importance of this mRNA target.
Another proapoptotic cellular gene product that has been shown to be a target of EBV miRNA is mRNA encoding Bim (BCL2L11), which seems to be a target of both miR-BART4 and miR-BART15 (refs. 20,41) . This activity is proposed to correlate with the observed inhibition of apoptosis by miRNAs of the BART cluster in the human gastric carcinoma cell line AGS.
A third reported target for the EBV BART miRNAs is the mRNA encoding MICB (major histocompatibility complex class I-related chain B), a stress-induced ligand of the natural killer cell-activating receptor NKG2D that serves a key role in promoting the natural killer cell-mediated killing of virus-infected cells 42 . This was actually first identified as a target of the HCMV-encoded miRNA miR-UL112 (ref. 43 ), but subsequent data have suggested that the mRNA encoding MICB is also targeted by the KSHV miRNA miR-K7 and by EBV miRNAs of the BART cluster 42 . As expected, miRNA-mediated downregulation of MICB mRNA expression has been shown to protect cells from being killed by natural killer cells in vitro 42 . CLIP analysis has subsequently documented binding sites for the EBV miRNAs miR-BART1, miR-BART3, miR-BART5 and miR-BART9 in the 3′ UTR of the mRNA encoding MICB 20, 21 . The fact that the mRNA encoding MICB is targeted not only by miRNAs encoded by several herpesvirus species but also by several distinct EBV miRNAs strongly suggests that attenuation of MICB function is highly advantageous to viruses in vivo. Indeed, in the case of HCMV, expression of MICB mRNA is also inhibited by a virus-encoded protein, UL16, that acts synergistically with miR-UL112 (ref. 43 ).
An interesting final point is that EBV miRNAs target not only host cellular mRNAs but also viral mRNAs. For example, the EBV miRNA miR-BART2 is positioned directly antisense to the mRNA encoding the viral DNA polymerase BALF5 (ref. 24 ). This antisense location has been observed before for several viral miRNAs, including the single pre-miRNAs encoded by all members of the polyomavirus family, which are encoded antisense to the viral large T antigen 25, 44 , and the miRNA miR-H2 encoded by herpes simplex virus (HSV) type 1, which is positioned antisense to the mRNA encoding the HSV ICP0 protein 45 . In the case of the polyomavirus SV40, it was proposed that expression of miRNA encoded by this virus late in the viral replication cycle inhibits expression of T antigen and thereby diminishes the killing of SV40-infected cells by cytotoxic T lymphocytes (CTLs) in vivo 44 . In contrast, inhibition of ICP0 expression by miR-H2 and inhibition of BALF5 expression by miR-BART2 has been proposed to stabilize viral latency 45, 46 , although neither of these proposals has so far been confirmed experimentally.
The miRNAs encoded by KSHV have been perhaps the most intensely studied viral miRNAs, and many mRNA targets of KSHV miRNAs have been defined ( Table 2 ). The miRNA miR-K10 targets the mRNA encoding the proapoptotic tumor-necrosis factor-related receptor TWEAKR 47 . This targeting, which diminishes the sensitivity of miR-K10-expressing cells to proapoptotic stimuli, has been further confirmed by CLIP 23 . Expression of the kinase IRAK1 and adaptor MyD88, which are components of the human Toll-like receptor (TLR)-interleukin 1 (IL-1) receptor signaling cascade, is downregulated by the KSHV miRNAs miR-K9 and miR-K5, respectively 48 . The expression of these two miRNAs in endothelial cells has been shown to inhibit production of the proinflammatory cytokines IL-6 and IL-8 after treatment of the cells with IL-1α, and this activity may inhibit the clearance of KSHV-infected cells in vivo by the immune system 48 . The KSHV miRNA miR-K10 is also proposed to target the mRNA encoding the type II receptor for transforming growth factor-β (TGF-β), which has been shown to inhibit TGF-β-induced apoptosis in culture 49 . Such targeting may again promote the survival of KSHV-infected endothelial cells in culture. Another protein involved in apoptosis whose mRNA is targeted by KSHV miRNAs is the key effector protein caspase-3, whose expression is attenuated by miR-K1, miR-K3 and miR-K4 (ref. 50) . When the activity of these viral miRNAs is inhibited, both the abundance of caspase-3 and apoptosis increase substantially. A final host cellular As noted above, HCMV strongly inhibits MICB expression by both protein-and miRNA-mediated mechanisms 43 . Another cellular factor targeted by HCMV miRNAs is the mRNA encoding ERAP1, an aminopeptidase that is important for the appropriate presentation of antigenic viral peptides to CTLs 52 . As a result, the relevant HCMV miRNA, miR-US4-1, is able to diminish the susceptibility of HCMVinfected cells to CTL-mediated killing. Finally, the HCMV miRNA miR-UL148D has been shown to target the mRNA encoding the important chemokine RANTES, which attracts cells of the immune response to sites of inflammation and tissue damage 53 . Blocking RANTES expression obviously could prevent the recruitment of effector cells of the immune response to infected cells in vivo.
Viral subversion of cellular miRNA function Cellular miRNAs are highly conserved during evolution (for example, the let-7 miRNA family is conserved from nematodes to humans 54 ), and many mRNA targets of cellular miRNAs are also conserved 3 . In this way, cells are able to use miRNAs to regulate logically coherent sets of mRNA species despite the fact that miRNA seed targets are only about seven nucleotides in length and are thus predicted to occur by chance every 4 7 (16,384) nucleotides. In contrast, viral miRNAs presumably promote viral replication at the expense of the host, and the targets of viral miRNAs are therefore, if anything, subject to negative selection. As a result, it might be predicted that viral miRNAs would have evolved to be perfectly complementary to perhaps only a single deleterious host cellular mRNA that they would then strongly inhibit by endonucleolytic cleavage. In fact, however, viral miRNAs do not generally show perfect complementarity to any mRNA, the main exception being the antisense viral mRNAs mentioned previously. Therefore, it can be hypothesized that viral miRNAs have probably evolved seed sequences that target nonconserved 3′ UTR sequences present on a small number of functionally relevant host cellular mRNAs, as well as a larger number of other host cellular mRNAs whose downregulation at least does not substantially inhibit viral replication.
Although de novo evolution of a useful viral miRNA, especially in the face of possible host-cell adversarial evolution, is therefore challenging, viruses do have the option of simply expressing a miRNA that mimics a host cellular miRNA, if that cellular miRNA has an activity that is potentially helpful to the virus. Analysis of the seed sequences of known viral miRNAs and cellular miRNAs has in fact shown that the former have a tendency to share the seed sequences of cellular miRNAs that is much higher than would be predicted by chance alone 25 . Although shared seed sequences obviously indicate a shared miRNA targetome, this has been demonstrated only for a small number of viral miRNAs 55 . The most intensively investigated example of a host cellular miRNA with a viral miRNA mimic is the host cellular miRNA miR-155, which is transiently induced after activation of both lymphoid and myeloid cells and has been shown to be important during the antigenic stimulation of T lymphocytes and B lymphocytes 56, 57 . Moreover, there is extensive evidence linking constitutive expression of miR-155 to the oncogenic transformation of cells, especially lymphoid cells [58] [59] [60] . The first viral mimic of miR-155 to be described was the KSHV miRNA miR-K11, shown by two groups to both share the full seed sequence of miR-155 (Fig. 2) and to also target a very similar set of cellular mRNAs 23, 61, 62 . Indeed, miR-K11 can even substitute for miR-155 in promoting hematopoiesis in vivo 63 ! Subsequently, a second miR-155 analog, miR-M4, was identified in the avian α-herpesvirus Marek's disease virus type 1 (MDV1) 64 . MDV1 causes T cell lymphomas in chickens, and these tumors have high expression of miR-M4. Notably, an MDV1 mutant lacking miR-M4 has been found to replicate normally in culture but fail to induce any tumors in vivo, whereas replacement of miR-M4 with cellular miR-155 restores such oncogenic potential in a 'revertant' MDV1 mutant. That result suggests that the miR-155 analog encoded by KSHV probably also has a critical role in the transformation of infected human B cells in vivo.
Although a virus can certainly evolve a viral miRNA that mimics the function of a host cellular miRNA, it is also possible for a virus to simply induce the expression of a cellular miRNA in infected cells. Although viral infection has been shown to affect cellular mRNA expression in many experimental systems, and this has been proposed to potentially facilitate viral replication 65 , this is perhaps most clearly demonstrated in the case of EBV. EBV strongly induces the expression of several host cellular miRNAs after infecting primary B cells in culture, and this infection, as noted above, leads to the outgrowth of transformed lymphoblastoid cell lines 66, 67 . One host cellular miRNA that is particularly strongly induced is miR-155, whose expression increases by ~200-fold within days of EBV infection [66] [67] [68] . This is probably due to activation of the host cellular transcription factor NF-κB by the EBV oncoprotein LMP1, which in turn results in more primary miR-155 transcription 69 . EBV does not encode an analog of miR-155, so this finding suggests the possibility that EBV has evolved an alternative mechanism to inhibit the host cellular mRNAs targeted by miR-155 and to promote the growth and transformation of B cells. Indeed, inhibition of miR-155 function in both EBVinfected lymphoblastoid cell lines and EBV + diffuse large B cell lymphoma cells has been found to induce cell-cycle arrest and strongly promote apoptosis 70 . These data therefore identify a critical role for miR-155 in the transformation of lymphoid cells by several oncogenic herpesviruses that infect humans and nonhuman species and suggest that manipulation of the pattern of miRNA expression by viruses may have a critical role in viral replication and pathogenesis in several different disease contexts.
Cellular miRNAs regulate viral replication
As noted above for EBV, viruses can certainly use host cellular miRNAs to their advantage and indeed, in the case of HCV, it is known that the liver-specific cellular miRNA miR-122 is essential for productive virus replication 71 . Interestingly, the ability of miR-122 to enhance HCV replication results from an unconventional activity of miR-122, which binds two sites near the 5′ end of HCV genomic npg r e v i e w RNA and seems to prevent recognition of that 5′ end, which bears a terminal triphosphate, by cellular factors of the innate immune system 72 . Another possibility is that host cellular miRNAs could act to substantially inhibit viral replication. Cellular miRNAs are expressed in a very tissue-specific manner, and the pattern of miRNA expression can therefore not only vary substantially across different tissue types but also, for example, vary depending on whether a cell's growth is arrested or the cell is actively dividing 3 . Each host cell expresses dozens of miRNAs, each of which has the potential to bind to and inhibit viral mRNA species. The issue of how viruses are able to replicate in the face of this potential innate cellular restriction mechanism is therefore of considerable interest. One possible explanation is that viruses could simply block host cellular miRNA function, either selectively or globally. Two examples are now known of viruses that use RNA 'decoys' to bind and destabilize a specific host cellular miRNA 73, 74 . Interestingly the same host miRNA, miR-27, is inhibited by both the simian herpesvirus saimiri and MCMV. In the latter case, restoration of miR-27 expression has been found to inhibit MCMV replication 74 , although this seems to be due to targeting of host cellular, not viral, mRNA species.
Two virus families have also been found to globally block host miRNA expression or function. The best documented case is the global degradation of host miRNAs induced by members of the poxvirus family, which encode a protein that induces the 3′-polyadenylation of miRNAs, which then induces degradation of the miRNA by the host cell 26 . In the case of adenovirus, it has been demonstrated that the viral noncoding RNA VA1 competitively inhibits both the exportin 5-mediated export of pre-miRNA and the Dicer-mediated processing of pre-miRNA, thus strongly inhibiting miRNA biogenesis 75, 76 .
Despite such interesting examples of virus-mediated inhibition of host cellular miRNA function, it is clear that most virus-infected cells retain the ability to use host miRNAs to regulate mRNA function. Indeed, several groups have used this fact to control viral tropism by engineering perfect target sites for particular tissue-specific cellular miRNAs in the viral genome, thus preventing the virus from being able to replicate effectively in that tissue [77] [78] [79] . This approach shows considerable promise for the development of attenuated virus vaccines and in the design of oncolytic viruses that can grow in and kill cancer cells but spare adjoining normal cells. The question remains of how viruses normally evade inhibition by host cellular miRNAs, given that a cursory bioinformatics analysis has shown that viruses often contain large numbers of potential seed-target sites for cellular miRNAs, including miRNAs expressed in their normal target tissues 80 . One hypothesis that can explain why this is apparently not a general problem is that viral RNA transcripts are highly structured and that potential target sites for miRNA are therefore occluded. Indeed, several RNA viruses, including HIV-1, seem to be highly structured, whereas others, such as poliovirus, seem to be fairly unstructured 81, 82 . As poliovirus RNAs are uncapped, and the lack of a cap structure has been reported to prevent translational inhibition by miRNA 83, 84 , it is possible that there might be a correlation between a high degree of viral RNA secondary structure and predicted susceptibility to inhibition by the RISC. Regardless of what proves to be true, it will certainly be interesting to determine whether host cellular miRNAs are indeed able to bind viral mRNAs effectively and to what degree such binding affects viral replication either positively, as seen for HCV 71 , or negatively, as would be predicted given the repressive activity that is normally characteristic of miRNA 80, 85 . Clearly, understanding of how viruses interact with the host's cellular miRNA machinery remains at an early stage, and research in this area may still provide many surprises.
